Inhibition of expression of vascular endothelial growth factor and its receptors in pulmonary adenocarcinoma cell by TNP-470 in combination with gemcitabine. [electronic resource]
Producer: 20070103Description: 837-43 p. digitalISSN:- 1673-1581
- Adenocarcinoma -- drug therapy
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cell Line, Tumor
- Cell Proliferation
- Cyclohexanes -- administration & dosage
- Deoxycytidine -- administration & dosage
- Disease Progression
- Gene Expression Regulation, Neoplastic
- Humans
- Lung Neoplasms -- drug therapy
- Neoplasm Metastasis
- O-(Chloroacetylcarbamoyl)fumagillol
- Protein Structure, Tertiary
- Sesquiterpenes -- administration & dosage
- Vascular Endothelial Growth Factor A -- biosynthesis
- Vascular Endothelial Growth Factor Receptor-1 -- biosynthesis
- Vascular Endothelial Growth Factor Receptor-2 -- biosynthesis
- Gemcitabine
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.